Projects

Establishing the INPHOG network of hospital – based childhood cancer registries (HBCCRs) in India (INPHOG : Indian Paediatric Hemaology Oncology Group, HBCCR: Hospital – Based Childhood Cancer Registry)

Project Description

Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.

Project Duration

2024 - 2026

Project Lead

Authors

Dr. Anand Prakash

Project Status

ongoing